Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Cocktail and Poster Display session

69P - Deregulation of hippo pathway kinases in uveal melanoma: Implications for prognosis and therapeutic targets

Date

26 Feb 2024

Session

Cocktail and Poster Display session

Topics

Targeted Therapy

Tumour Site

Presenters

Nikhil Kumar

Citation

Annals of Oncology (2024) 9 (suppl_1): 1-11. 10.1016/esmoop/esmoop102271

Authors

N. Kumar1, L. Singh2, M.K. Singh3, S. Sen1, R. Meel4, N. Lomi4, S. Kashyap5

Author affiliations

  • 1 Ocular Pathology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi, Delhi/IN
  • 2 Pediatrics, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 3 Department Of Ophthalmology, UT Southwestern Medical Center, 75390 - Dallas/US
  • 4 Department Of Ophthalmology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 5 Ocular Pathology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN

Resources

This content is available to ESMO members and event participants.

Abstract 69P

Background

Hippo pathway consists of a kinase cascade and regulatory components, whose aberrant expression contributes to oncogenesis. Uveal melanoma (UM) is a treatment-resistant intraocular malignancy in adults, with limited therapeutic options and high metastasis rates. Oncogenomic analyses of UM tumors revealed widespread genomic alterations of GNAQ/11 gene affecting multiple pathways. Hippo pathway appears to play a major role in regulating tumor progression and may represent a promising target for novel therapies in UM. Therefore, we elucidate the differential expression of Hippo pathway kinases and their association with high-risk clinicopathological parameters and their impact on the prognosis of UM patients.

Methods

Quantitative Real-Time PCR (qRT-PCR) was used to determine the mRNA expression level of 9 Hippo kinases (MST1, MST2, LATS1, LATS2, SAV1, MOB1A, MOB1B, NDR1 and NDR2,) in 32 prospective UM cases and correlated with clinicopathological parameters along with patient outcome.

Results

Sixty percent patients exhibited advanced tumor staging with a male preponderance (68.7%). High pigmentation and scleral invasion were present in 65.6% and 31.2% cases, respectively. The mRNA expression levels of LATS1, LATS2, SAV1, MOB1A and NDR1 genes were found to be downregulated in more than 50% of cases, with mean fold changes of 0.38, 1.07, 1.54, 1.39, and 0.77, respectively. Conversely, MST1, MST2, MOB1B and NDR2 were upregulated in more than 50% of cases, with mean fold changes of 2.18, 3.14, 2.09, and 4.09, respectively. Six patients developed distant metastasis of which four died due to the disease.

Conclusions

Our data reveal substantial mRNA-level deregulation of Hippo pathway kinases in UM patients. Downregulation of these kinases contributes to UM aggressiveness. These findings may pave the way for developing predictive biomarkers and therapeutic targets for management and treatment of UM. However, additional investigations are required in understanding the precise mechanisms of Hippo signaling components, and will also help in realizing the potential of therapeutics to modulate central mediators (YAP/TAZ) protein activity and suppressing oncogenesis.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Indian Council of Medical Research.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.